Suppr超能文献

子宫内膜癌手术绝经与非酒精性脂肪性肝病风险增加

Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer.

作者信息

Matsuo Koji, Gualtieri Marc R, Cahoon Sigita S, Jung Carrie E, Paulson Richard J, Shoupe Donna, Muderspach Laila I, Wakatsuki Akihiko, Wright Jason D, Roman Lynda D

机构信息

1Division of Gynecologic Oncology, University of Southern California, Los Angeles, CA 2Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 3Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA 4Department of Obstetrics and Gynecology, Aichi Medical University, Aichi, Japan 5Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY.

出版信息

Menopause. 2016 Feb;23(2):189-96. doi: 10.1097/GME.0000000000000500.

Abstract

OBJECTIVE

Our objective was to examine risk factors associated with development of nonalcoholic fatty liver disease (NAFLD) among women with endometrial cancer who underwent surgical staging with or without oophorectomy.

METHODS

This is a retrospective study that evaluated endometrial cancer cases that underwent surgical staging (n = 666) and endometrial hyperplasia cases that underwent hysterectomy-based treatment (n = 209). This study included 712 oophorectomy cases and 163 nonoophorectomy cases. Archived records were reviewed for participant demographics, medical comorbidities, operative notes, histology results, and radiology reports for NAFLD. Cumulative risks of NAFLD after surgical operation were correlated to demographics and medical comorbidities.

RESULTS

The cumulative prevalence of NAFLD in 875 women with endometrial tumor was 14.1%, 20.5%, and 38.4% at 1, 2, and 5 years after surgical operation, respectively. On multivariate analysis, after controlling for age, ethnicity, body mass index, medical comorbidities, tumor type, hormonal treatment pattern, and oophorectomy status, age younger than 40 years (2-y cumulative prevalence, 26.6% vs 16.8%; hazard ratio [HR], 1.85; 95% CI, 1.27-2.71; P = 0.001) and age 40 to 49 years (2-y cumulative prevalence, 23.1% vs 16.8%; HR, 1.49; 95% CI, 1.08-2.04; P = 0.015) remained significant predictors for developing NAFLD after surgical operation compared with age 50 years or older. Oophorectomy was an independent predictor for increased risk of NAFLD (20.9% vs 15.9%; HR, 1.70; 95% CI, 1.01-2.86; P = 0.047). In addition, NAFLD was significantly associated with postoperative development of diabetes mellitus (39.2% vs 15.3%; HR, 2.26; 95% CI, 1.52-3.35; P < 0.0001) and hypercholesterolemia (34.3% vs 17.5%; HR, 1.71; 95% CI, 1.12-2.63; P = 0.014).

CONCLUSIONS

Oophorectomy in young women with endometrial cancer significantly increases the risk of NAFLD. This is associated with development of diabetes mellitus and hypercholesterolemia after oophorectomy.

摘要

目的

我们的目的是研究在接受或未接受卵巢切除术进行手术分期的子宫内膜癌女性中,与非酒精性脂肪性肝病(NAFLD)发生相关的危险因素。

方法

这是一项回顾性研究,评估了接受手术分期的子宫内膜癌病例(n = 666)和接受子宫切除术治疗的子宫内膜增生病例(n = 209)。本研究包括712例卵巢切除术病例和163例非卵巢切除术病例。查阅存档记录,了解参与者的人口统计学信息、合并症、手术记录、组织学结果以及NAFLD的放射学报告。手术操作后NAFLD的累积风险与人口统计学和合并症相关。

结果

875例患有子宫内膜肿瘤的女性中,NAFLD的累积患病率在手术后1年、2年和5年分别为14.1%、20.5%和38.4%。多因素分析显示,在控制年龄、种族、体重指数、合并症、肿瘤类型、激素治疗模式和卵巢切除术状态后,与50岁及以上相比,年龄小于40岁(2年累积患病率,26.6%对16.8%;风险比[HR],1.85;95%置信区间[CI],1.27 - 2.71;P = 0.001)和40至49岁(2年累积患病率,23.1%对16.8%;HR,1.49;95% CI,1.08 - 2.04;P = 0.015)仍然是手术后发生NAFLD的显著预测因素。卵巢切除术是NAFLD风险增加的独立预测因素(20.9%对15.9%;HR,1.70;95% CI,1.01 - 2.86;P = 0.047)。此外,NAFLD与术后糖尿病的发生显著相关(39.2%对15.3%;HR,2.26;95% CI,1.52 - 3.35;P < 0.0001)和高胆固醇血症(34.3%对17.5%;HR,1.71;95% CI,1.12 - 2.63;P = 0.014)。

结论

年轻子宫内膜癌女性进行卵巢切除术会显著增加NAFLD的风险。这与卵巢切除术后糖尿病和高胆固醇血症的发生有关。

相似文献

1
Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer.
Menopause. 2016 Feb;23(2):189-96. doi: 10.1097/GME.0000000000000500.
2
Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.
Clin Appl Thromb Hemost. 2017 Nov;23(8):1018-1027. doi: 10.1177/1076029616665925. Epub 2016 Aug 31.
3
Contributing factors for menopausal symptoms after surgical staging for endometrial cancer.
Menopause. 2016 May;23(5):535-43. doi: 10.1097/GME.0000000000000576.
4
Association of hysterectomy with nonalcoholic fatty liver disease among US women.
Lipids Health Dis. 2024 Jan 31;23(1):34. doi: 10.1186/s12944-024-02020-4.
5
Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women.
Climacteric. 2020 Apr;23(2):173-177. doi: 10.1080/13697137.2019.1650018. Epub 2019 Sep 20.
6
Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.
Gynecol Oncol. 2019 Apr;153(1):123-126. doi: 10.1016/j.ygyno.2019.01.009. Epub 2019 Jan 14.
10
Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink.
Eur J Epidemiol. 2019 Sep;34(9):871-878. doi: 10.1007/s10654-019-00526-1. Epub 2019 Jun 4.

引用本文的文献

1
The Ovary-Liver Axis: Molecular Science and Epidemiology.
Int J Mol Sci. 2025 Jul 2;26(13):6382. doi: 10.3390/ijms26136382.
2
Unraveling the link between metabolic dysfunction-associated steatotic liver disease and osteoporosis: a bridging function of gut microbiota.
Front Endocrinol (Lausanne). 2025 Apr 1;16:1543003. doi: 10.3389/fendo.2025.1543003. eCollection 2025.
3
Hormone replacement therapy for steatotic liver management after surgical menopause.
Clin J Gastroenterol. 2025 Apr;18(2):352-356. doi: 10.1007/s12328-024-02090-y. Epub 2025 Jan 6.
4
Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019.
J Nutr Health Aging. 2024 Jun;28(6):100261. doi: 10.1016/j.jnha.2024.100261. Epub 2024 May 28.
5
Association of hysterectomy with nonalcoholic fatty liver disease among US women.
Lipids Health Dis. 2024 Jan 31;23(1):34. doi: 10.1186/s12944-024-02020-4.
6
Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women.
Clin Gastroenterol Hepatol. 2024 Feb;22(2):339-346.e5. doi: 10.1016/j.cgh.2023.08.020. Epub 2023 Sep 9.
8
Pre- and Post-Sexual Maturity Liver-specific ERα Knockout Does Not Impact Hepatic Mitochondrial Function.
J Endocr Soc. 2023 Apr 27;7(6):bvad053. doi: 10.1210/jendso/bvad053. eCollection 2023 May 5.

本文引用的文献

2
Cancer statistics, 2015.
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
3
Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Ann Surg Oncol. 2014 Dec;21(13):4246-55. doi: 10.1245/s10434-014-3880-6. Epub 2014 Jul 8.
4
Obesity in the United States - dysbiosis from exposure to low-dose antibiotics?
Front Public Health. 2013 Dec 19;1:69. doi: 10.3389/fpubh.2013.00069. eCollection 2013.
5
Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats.
Endocrinology. 2014 Feb;155(2):417-28. doi: 10.1210/en.2013-1648. Epub 2013 Nov 26.
6
Take 'em or leave 'em: management of the ovaries in young women with endometrial cancer.
Gynecol Oncol. 2013 Nov;131(2):287-8. doi: 10.1016/j.ygyno.2013.09.026.
7
Noninvasive evaluation of NAFLD.
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):666-75. doi: 10.1038/nrgastro.2013.175. Epub 2013 Sep 24.
9
Type I and II endometrial cancers: have they different risk factors?
J Clin Oncol. 2013 Jul 10;31(20):2607-18. doi: 10.1200/JCO.2012.48.2596. Epub 2013 Jun 3.
10
Nonalcoholic fatty liver disease: current issues and novel treatment approaches.
Drugs. 2013 Jan;73(1):1-14. doi: 10.1007/s40265-012-0004-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验